279 related articles for article (PubMed ID: 32433544)
21. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis.
Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B
Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441
[TBL] [Abstract][Full Text] [Related]
22. EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma.
Xu S; Zhou Z; Peng X; Tao X; Zhou P; Zhang K; Peng J; Li D; Shen L; Yang L
Cell Death Dis; 2021 Apr; 12(4):344. PubMed ID: 33795637
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma.
Guo L; Tang M; Yang L; Xiao L; Bode AM; Li L; Dong Z; Cao Y
Int J Mol Med; 2012 Apr; 29(4):574-80. PubMed ID: 22266808
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells.
Yu H; Lu J; Zuo L; Yan Q; Yu Z; Li X; Huang J; Zhao L; Tang H; Luo Z; Liao Q; Zeng Z; Zhang J; Li G
J Virol; 2012 Mar; 86(6):3088-99. PubMed ID: 22205737
[TBL] [Abstract][Full Text] [Related]
25. Capn4 is induced by and required for Epstein-Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP-1 signaling.
Zheng P; Chen X; Xie J; Chen X; Lin S; Ye L; Chen L; Lin J; Yu X; Zheng M
Cancer Sci; 2020 Jan; 111(1):72-83. PubMed ID: 31691433
[TBL] [Abstract][Full Text] [Related]
26. EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma.
Lu J; Tang M; Li H; Xu Z; Weng X; Li J; Yu X; Zhao L; Liu H; Hu Y; Tan Z; Yang L; Zhong M; Zhou J; Fan J; Bode AM; Yi W; Gao J; Sun L; Cao Y
Cancer Lett; 2016 Sep; 380(1):191-200. PubMed ID: 27255972
[TBL] [Abstract][Full Text] [Related]
27. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
Chang PY; Wu ZZ; Sun NK; Chao CC
J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
[TBL] [Abstract][Full Text] [Related]
28. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
[TBL] [Abstract][Full Text] [Related]
29. Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.
Hau PM; Tsang CM; Yip YL; Huen MS; Tsao SW
PLoS One; 2011; 6(6):e21176. PubMed ID: 21701587
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-encoded latent membrane protein 1 promotes extracellular vesicle secretion through syndecan-2 and synaptotagmin-like-4 in nasopharyngeal carcinoma cells.
Liao C; Zhou Q; Zhang Z; Wu X; Zhou Z; Li B; Peng J; Shen L; Li D; Luo X; Yang L
Cancer Sci; 2020 Mar; 111(3):857-868. PubMed ID: 31930596
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
33. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.
Tao Y; Song X; Deng X; Xie D; Lee LM; Liu Y; Li W; Li L; Deng L; Wu Q; Gong J; Cao Y
Exp Cell Res; 2005 Feb; 303(2):240-51. PubMed ID: 15652339
[TBL] [Abstract][Full Text] [Related]
34. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells.
Mei YP; Zhou JM; Wang Y; Huang H; Deng R; Feng GK; Zeng YX; Zhu XF
Cell Cycle; 2007 Jun; 6(11):1379-85. PubMed ID: 17507800
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.
Liu HP; Chen CC; Wu CC; Huang YC; Liu SC; Liang Y; Chang KP; Chang YS
PLoS Pathog; 2012; 8(5):e1002690. PubMed ID: 22589722
[TBL] [Abstract][Full Text] [Related]
36. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway.
Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ
Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Endo K; Nakanishi Y; Aga M; Kobayashi E; Hirai N; Sugimoto H; Hatano M; Ueno T; Ishikawa K; Wakisaka N
Cancer Sci; 2018 Feb; 109(2):272-278. PubMed ID: 29247573
[TBL] [Abstract][Full Text] [Related]
38. EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.
Fang W; Zhang J; Hong S; Zhan J; Chen N; Qin T; Tang Y; Zhang Y; Kang S; Zhou T; Wu X; Liang W; Hu Z; Ma Y; Zhao Y; Tian Y; Yang Y; Xue C; Yan Y; Hou X; Huang P; Huang Y; Zhao H; Zhang L
Oncotarget; 2014 Dec; 5(23):12189-202. PubMed ID: 25361008
[TBL] [Abstract][Full Text] [Related]
39. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.
Xiao L; Hu ZY; Dong X; Tan Z; Li W; Tang M; Chen L; Yang L; Tao Y; Jiang Y; Li J; Yi B; Li B; Fan S; You S; Deng X; Hu F; Feng L; Bode AM; Dong Z; Sun LQ; Cao Y
Oncogene; 2014 Sep; 33(37):4568-78. PubMed ID: 24662831
[TBL] [Abstract][Full Text] [Related]
40. Targeting EZH2 depletes LMP1-induced activated regulatory T cells enhancing antitumor immunity in nasopharyngeal carcinoma.
Sun W; Chen L; Tang J; Zhang C; Wen Y; Wen W
J Cancer Res Ther; 2020; 16(2):309-319. PubMed ID: 32474518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]